Investor Resources

Robust IP Protection

Multiple issued & pending patents covering cell repair, ARS, viral inhibition, and food preservation.

Platform Technology

Synthetic surfactant chaperones that restore membrane integrity and prevent protein aggregation.

Commercial Versatility

Dual high-value therapeutic applications (in-vivo trauma) and industrial markets (food shelf-life).

Distinguished Leadership

Founded by MacArthur Fellow Dr. Raphael Lee with deep academic and biopharma industry experience.

Select Patents

Patent US-2024024354-A1

Methods for treating viral infections using amphiphilic block copolymers that target exposed hydrophobic viral domains to block replication, prevent tissue cell death, and promote cellular repair.

Patent US-9687502-B2

In vivo repair of damaged mammalian nerve tissue using targeted biomembrane fusion agents delivered via direct application or systemic parenteral administration.

Patent US-9572340-B2

Biocompatible multiblock copolymer surfactants engineered to catalyze protein refolding in aqueous solutions, restoring native conformation without altering protein composition across in vivo and in vitro stress conditions.

Publications Spotlight

Ischemia-Reperfusion

P188 Protects Against Ischemia-Reperfusion Injury In A Murine Hind-Limb Model

Neuroprotection

Amphiphilic, Tri-Block Copolymers Provide Potent, Membrane-Targeted Neuroprotection

Fixing A Hole (Cell Injury: Mechanisms, Responses, and Repair)

Maroon Biotech in the News

March 7, 2022 | The University of Chicago Polsky Center for Entrepreneurship and Innovation

October 17, 2017 | Page Ivey, University of South Carolina

February 2006 | Lydialyle Gibson, University of Chicago Magazine